Prevalence of Abnormal Postures in Parkinson's Disease

NCT ID: NCT03573232

Last Updated: 2018-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

794 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-07

Study Completion Date

2018-10-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postural abnormalities represent disabling and painful complications in patients with Parkinson's disease (PD). The stooped posture is a typical feature of PD but with advancing of disease more severe body abnormalities can affect people with PD. These deformities include Pisa syndrome, camptocormia, antecollis, scoliosis and striatal deformities related to hand (striatal hand) and/or toes (striatal toes).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postural abnormalities represent disabling and painful complications in patients with Parkinson's disease (PD). The first postural trunk deviation in PD was first described by James Parkinson himself and recognized as stooped simian appearance, with flexion of the hips and knees, and rounding of the shoulders. Although the stooped posture is a typical feature, more severe spinal misalignment (and deformities) can affect people with PD. These postural deformities include Pisa syndrome (PS), camptocormia (CP), antecollis (AC), scoliosis (S) and striatal deformities related to hand (striatal hand) and/or toes (striatal toes). The prevalence of these postural deformities is variable because several diagnostic criteria have been used to characterize each deformity. Recently, a consensus of diagnostic criteria has been reached in literature permitting us to better mapping the presence of these deformities in people with PD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Participants will be considered enrolled after signing the consent form;
2. Diagnosis of Parkinson's disease;

Exclusion Criteria

1. Concomitant neurologic diseases known to negatively affect posture;
2. A history of major spinal surgery or muscle and/or skeletal diseases;
3. Treatment with drugs potentially able to induce abnormal postures;
4. Clinical features consistent with a diagnosis of atypical parkinsonism;
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universita di Verona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michele Tinazzi, MD, PhD

M.D., Ph.D. Full Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michele Tinazzi, MD, PhD, Professor

Role: PRINCIPAL_INVESTIGATOR

Universita di Verona

Nicola Smania, MD, Professor

Role: STUDY_CHAIR

Universita di Verona

Marialuisa Gandolfi, MD, PhD

Role: STUDY_CHAIR

Universita di Verona

Christian Geroin, PhD

Role: STUDY_CHAIR

Universita di Verona

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Experimental and Clinical Medicine - University "Politecnica delle Marche" Ancona -Italy. Neurorehabilitation Clinic - Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona.

Ancona, , Italy

Site Status RECRUITING

Department of Neuroscience, Imaging and Clinical Sciences, University G.d'Annunzio of Chieti-Pescara

Pescara, , Italy

Site Status RECRUITING

Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Pisa, , Italy

Site Status RECRUITING

IRCCS San Raffaele CTC Centro Parkinson Via della Pisana 235, 00163 Roma

Roma, , Italy

Site Status RECRUITING

Dipartimento di Neuroscienze A.O. Città della Salute e della Scienza di Torino

Torino, , Italy

Site Status RECRUITING

Clinica Neurologica, Dipartimento di Scienze Neurologiche, Chirurgiche e della Salute, Azienda Ospedaliera Universitaria integrata, Universita' di Trieste

Trieste, , Italy

Site Status RECRUITING

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona

Verona, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Michele Tinazzi, MD, PhD, Professor

Role: CONTACT

0458124287

Christian Geroin, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marianna Capecci, MD, PhD

Role: primary

Laura Bonanni, MD, PhD

Role: primary

Roberto Ceravolo, MD, Professor

Role: primary

Fabrizio Stocchi, MD

Role: primary

Maurizio Zibetti, MD

Role: primary

Paolo Manganotti, MD, PhD

Role: primary

Michele Tinazzi, MD, PhD, Professor

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Doherty KM, van de Warrenburg BP, Peralta MC, Silveira-Moriyama L, Azulay JP, Gershanik OS, Bloem BR. Postural deformities in Parkinson's disease. Lancet Neurol. 2011 Jun;10(6):538-49. doi: 10.1016/S1474-4422(11)70067-9. Epub 2011 Apr 22.

Reference Type BACKGROUND
PMID: 21514890 (View on PubMed)

Tinazzi M, Geroin C, Gandolfi M, Smania N, Tamburin S, Morgante F, Fasano A. Pisa syndrome in Parkinson's disease: An integrated approach from pathophysiology to management. Mov Disord. 2016 Dec;31(12):1785-1795. doi: 10.1002/mds.26829. Epub 2016 Oct 25.

Reference Type BACKGROUND
PMID: 27779784 (View on PubMed)

Srivanitchapoom P, Hallett M. Camptocormia in Parkinson's disease: definition, epidemiology, pathogenesis and treatment modalities. J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):75-85. doi: 10.1136/jnnp-2014-310049. Epub 2015 Apr 20.

Reference Type BACKGROUND
PMID: 25896683 (View on PubMed)

Pandey S, Garg H. Postural & striatal deformities in Parkinson;s disease: Are these rare? Indian J Med Res. 2016 Jan;143(1):11-7. doi: 10.4103/0971-5916.178577.

Reference Type BACKGROUND
PMID: 26997007 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Università di Verona

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.